New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.
People on MSN4d
Mom Overdosed on Weight Loss Drug She Got on Instagram, Recalls 'Throwing Up Blood': 'Thought I Was Going to Die'Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved ...
News Nation on MSN2d
Ozempic can lead to muscle mass loss: StudyRecent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug ...
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback